Bottom line
How much do SHSSX and SCHLX overlap?
74% of their top holdings overlap by weight. 17 securities appear in both funds' top 25, making up 62.7% of SHSSX's assets and 65.4% of SCHLX's. They are largely the same portfolio — owning both adds little diversification.
SHSSX holds far more positions (155 vs 65), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings SHSSX and SCHLX have in common
| Holding | % of SHSSX | % of SCHLX | Overlap |
|---|---|---|---|
| Eli Lilly & Company LLY | 12.29% | 13.85% | 12.29% |
| Johnson & Johnson JNJ | 8.77% | 6.19% | 6.19% |
| Unitedhealth Group Inc UNH | 6.10% | 5.73% | 5.73% |
| Merck & Company Inc MRK | 4.94% | 4.85% | 4.85% |
| Gilead Sciences Inc GILD | 4.19% | 2.78% | 2.78% |
| Abbvie Inc ABBV | 3.94% | 4.90% | 3.94% |
| Amgen Inc AMGN | 3.37% | 2.88% | 2.88% |
| Thermo Fisher Scientific Inc TMO | 3.02% | 3.46% | 3.02% |
| Vertex Pharmaceuticals Inc VRTX | 2.74% | 2.45% | 2.45% |
| Pfizer Inc PFE | 2.61% | 1.17% | 1.17% |
| Danaher Corp DHR | 2.00% | 2.13% | 2.00% |
| Abbott Laboratories ABT | 1.97% | 2.39% | 1.97% |
| Intuitive Surgical Inc ISRG | 1.95% | 2.69% | 1.95% |
| Boston Scientific Corp BSX | 1.59% | 2.10% | 1.59% |
| Astrazeneca Plc AZN | 1.21% | 3.80% | 1.21% |
| Stryker Corp SYK | 1.15% | 2.61% | 1.15% |
| Regeneron Pharmaceuticals Inc REGN | 0.91% | 1.43% | 0.91% |
Source: SEC Form N-PORT (periods May 29, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in SHSSX
- Edwards Lifesciences Corp — 2.51%
- Teva Pharmaceutical Industries Ltd — 1.87%
- Elevance Health Inc — 1.56%
- Argenx Se — 1.26%
- Biogen Inc — 1.21%
- Blackrock Funds III — 1.01%
- Revolution Medicines Inc — 0.96%
- Humana Inc — 0.92%
Only in SCHLX
- Novartis AG — 2.90%
- McKesson Corp — 2.05%
- Novo Nordisk A/S — 1.73%
- Medtronic PLC — 1.54%
- Bristol-Myers Squibb Co — 1.50%
- Cardinal Health Inc — 1.34%
- Cencora Inc — 1.26%
- Roche Holding AG — 1.24%
Asset mix
| Asset type | SHSSX | SCHLX |
|---|---|---|
| Stocks | 99.8% | 99.6% |
| Cash & short-term funds | 1.4% | 0.5% |
Source: SEC Form N-PORT (periods May 29, 2026 / May 31, 2026)
Country mix
| Country | SHSSX | SCHLX |
|---|---|---|
| US | 93.9% | 85.7% |
| CH | 1.4% | 5.2% |
| GB | 1.4% | 3.8% |
| IL | 1.9% | — |
| DK | — | 1.7% |
| IE | — | 1.5% |
| NL | 1.3% | 1.0% |
| FR | — | 1.0% |
Source: SEC Form N-PORT (periods May 29, 2026 / May 31, 2026)
Check another pair
FAQ
How much do SHSSX and SCHLX overlap?
What stocks do SHSSX and SCHLX have in common?
Should I own both SHSSX and SCHLX?
Which holds more stocks, SHSSX or SCHLX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.